Exelixis Inc. buy Guggenheim
Start price
22.01.25
/
50%
€32.38
Target price
22.01.26
-
Performance (%)
15.84%
End price
23.01.26
€37.51
Summary
This prediction ended on 23.01.26 with a price of €37.51. The prediction had a final performance of 15.84%. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exelixis Inc. | -3.123% | -3.123% | 33.460% |
| iShares Core DAX® | 0,88 % | 5,63 % | 8,48 % |
| iShares Nasdaq 100 | 2,39 % | 1,57 % | 28,41 % |
| iShares Nikkei 225® | 4,27 % | 2,52 % | 50,98 % |
| iShares S&P 500 | 1,17 % | 2,55 % | 23,60 % |
Comments by Guggenheim for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for EXEL provided by MarketBeat
In the thread Trading Exelixis Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten